FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W627231601> ?p ?o ?g. }

• W627231601 endingPage "3318" @default.
• W627231601 startingPage "3309" @default.
• W627231601 abstract "Emerging preclinical evidence suggests that imidazoline I2 receptor ligands may be effective analgesics. Quantitative analysis of the combined I2 receptor ligands and opioids is needed for the justification of combination therapy. This study systematically examined the anti-hyperalgesic and response rate-suppressing effects of selective I2 receptor ligands (2-BFI and phenyzoline) alone and in combination with oxycodone in rats. Von Frey filament test was used to examine the anti-hyperalgesic effects of drugs in a rat model of complete Freund’s adjuvant (CFA)-induced inflammatory pain. Schedule-controlled responding was used to assess the rate-altering effects of study drugs. Duration of actions of individual drugs (2-BFI, phenyzoline, and oxycodone) alone or in combination was studied. Dose-addition analysis was employed to assess the anti-hyperalgesic interactions between drugs. Oxycodone (0.1–3.2 mg/kg, i.p.), 2-BFI (1–17.8 mg/kg, i.p.), and phenyzoline (17.8–56 mg/kg, i.p.) all dose-dependently produced significant antinociceptive effects. When studied as combinations, 2-BFI and oxycodone produced additive interactions while phenyzoline and oxycodone produced supra-additive interactions under all fixed ratios. The same drug combinations did not alter or significantly reduced the operant responding depending on the ratios of the drug combinations. Quantitative analysis of the anti-hyperalgesic effects of I2 receptor ligands strongly supports the therapeutic potential of I2 receptor ligands against inflammatory pain. In addition, the data reveal that phenyzoline is superior to the prototypic I2 receptor ligand 2-BFI for the management of pain and warrants further consideration as a novel analgesic." @default.
• W627231601 created "2016-06-24" @default.
• W627231601 creator A5007550740 @default.
• W627231601 creator A5035865091 @default.
• W627231601 creator A5053506930 @default.
• W627231601 creator A5060955235 @default.
• W627231601 date "2015-06-04" @default.
• W627231601 modified "2023-09-23" @default.
• W627231601 title "Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone" @default.
• W627231601 cites W1481010882 @default.
• W627231601 cites W1578357875 @default.
• W627231601 cites W1583072860 @default.
• W627231601 cites W1604643098 @default.
• W627231601 cites W1901117276 @default.
• W627231601 cites W1915767302 @default.
• W627231601 cites W1966899884 @default.
• W627231601 cites W1974768737 @default.
• W627231601 cites W1991431163 @default.
• W627231601 cites W1991933561 @default.
• W627231601 cites W1998754400 @default.
• W627231601 cites W2001467169 @default.
• W627231601 cites W2009954805 @default.
• W627231601 cites W2028452244 @default.
• W627231601 cites W2033921064 @default.
• W627231601 cites W2045403365 @default.
• W627231601 cites W2051250857 @default.
• W627231601 cites W2054140063 @default.
• W627231601 cites W2054947823 @default.
• W627231601 cites W2061434894 @default.
• W627231601 cites W2066480031 @default.
• W627231601 cites W2077956987 @default.
• W627231601 cites W2087454739 @default.
• W627231601 cites W2093685285 @default.
• W627231601 cites W2100980169 @default.
• W627231601 cites W2138109774 @default.
• W627231601 cites W2154941518 @default.
• W627231601 cites W2163703742 @default.
• W627231601 cites W2171872873 @default.
• W627231601 cites W4213219299 @default.
• W627231601 doi "https://doi.org/10.1007/s00213-015-3983-1" @default.
• W627231601 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4537836" @default.
• W627231601 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26037946" @default.
• W627231601 hasPublicationYear "2015" @default.
• W627231601 type Work @default.
• W627231601 sameAs 627231601 @default.
• W627231601 citedByCount "18" @default.
• W627231601 countsByYear W6272316012015 @default.
• W627231601 countsByYear W6272316012016 @default.
• W627231601 countsByYear W6272316012017 @default.
• W627231601 countsByYear W6272316012018 @default.
• W627231601 countsByYear W6272316012019 @default.
• W627231601 countsByYear W6272316012020 @default.
• W627231601 countsByYear W6272316012021 @default.
• W627231601 crossrefType "journal-article" @default.
• W627231601 hasAuthorship W627231601A5007550740 @default.
• W627231601 hasAuthorship W627231601A5035865091 @default.
• W627231601 hasAuthorship W627231601A5053506930 @default.
• W627231601 hasAuthorship W627231601A5060955235 @default.
• W627231601 hasBestOaLocation W6272316012 @default.
• W627231601 hasConcept C123605464 @default.
• W627231601 hasConcept C126322002 @default.
• W627231601 hasConcept C15490471 @default.
• W627231601 hasConcept C170493617 @default.
• W627231601 hasConcept C185592680 @default.
• W627231601 hasConcept C2776029756 @default.
• W627231601 hasConcept C2777389121 @default.
• W627231601 hasConcept C2780820201 @default.
• W627231601 hasConcept C2781063702 @default.
• W627231601 hasConcept C71924100 @default.
• W627231601 hasConcept C98274493 @default.
• W627231601 hasConceptScore W627231601C123605464 @default.
• W627231601 hasConceptScore W627231601C126322002 @default.
• W627231601 hasConceptScore W627231601C15490471 @default.
• W627231601 hasConceptScore W627231601C170493617 @default.
• W627231601 hasConceptScore W627231601C185592680 @default.
• W627231601 hasConceptScore W627231601C2776029756 @default.
• W627231601 hasConceptScore W627231601C2777389121 @default.
• W627231601 hasConceptScore W627231601C2780820201 @default.
• W627231601 hasConceptScore W627231601C2781063702 @default.
• W627231601 hasConceptScore W627231601C71924100 @default.
• W627231601 hasConceptScore W627231601C98274493 @default.
• W627231601 hasIssue "18" @default.
• W627231601 hasLocation W6272316011 @default.
• W627231601 hasLocation W6272316012 @default.
• W627231601 hasLocation W6272316013 @default.
• W627231601 hasLocation W6272316014 @default.
• W627231601 hasOpenAccess W627231601 @default.
• W627231601 hasPrimaryLocation W6272316011 @default.
• W627231601 hasRelatedWork W2072614072 @default.
• W627231601 hasRelatedWork W2092139176 @default.
• W627231601 hasRelatedWork W2148408061 @default.
• W627231601 hasRelatedWork W2162424811 @default.
• W627231601 hasRelatedWork W2170230856 @default.
• W627231601 hasRelatedWork W2937696636 @default.
• W627231601 hasRelatedWork W3129299578 @default.
• W627231601 hasRelatedWork W3173023943 @default.
• W627231601 hasRelatedWork W4206871862 @default.
• W627231601 hasRelatedWork W4287435042 @default.

• next